Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan
CONCLUSION: In this study, the addition of adjuvant treatment was associated with an OS benefit for patients with LVSI, especially those with grade 3 endometrioid tumors.PMID:38130137 | DOI:10.3802/jgo.2024.35.e33
Source: Journal of Gynecologic Oncology - Category: OBGYN Authors: Yoo-Young Lee Yen-Ling Lai Myeong-Seon Kim Koping Chang Hyun-Soo Kim Wen-Fang Cheng Yu-Li Chen Source Type: research
More News: Cancer | Cancer & Oncology | Carcinosarcoma | Endometrial Cancer | OBGYN | Study | Taiwan Health | Undifferentiated Carcinoma